Medivolve Inc
OTC:MEDVF

Watchlist Manager
Medivolve Inc Logo
Medivolve Inc
OTC:MEDVF
Watchlist
Price: 0.005 USD -16.67% Market Closed
Market Cap: 16.3m USD
Have any thoughts about
Medivolve Inc?
Write Note

Medivolve Inc
Revenue

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Medivolve Inc
Revenue Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Revenue CAGR 3Y CAGR 5Y CAGR 10Y
Medivolve Inc
OTC:MEDVF
Revenue
CA$686.5k
CAGR 3-Years
-60%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
A
Andlauer Healthcare Group Inc
TSX:AND
Revenue
CA$648m
CAGR 3-Years
27%
CAGR 5-Years
19%
CAGR 10-Years
N/A
WELL Health Technologies Corp
TSX:WELL
Revenue
CA$776.1m
CAGR 3-Years
149%
CAGR 5-Years
136%
CAGR 10-Years
N/A
dentalcorp Holdings Ltd
TSX:DNTL
Revenue
CA$1.4B
CAGR 3-Years
29%
CAGR 5-Years
19%
CAGR 10-Years
N/A
KDA Group Inc
XTSX:KDA
Revenue
CA$204.1k
CAGR 3-Years
-79%
CAGR 5-Years
-61%
CAGR 10-Years
N/A
H
Healwell Al Inc
TSX:AIDX
Revenue
CA$7.3m
CAGR 3-Years
-43%
CAGR 5-Years
-30%
CAGR 10-Years
N/A
No Stocks Found

Medivolve Inc
Glance View

Market Cap
16.3m USD
Industry
Health Care

Medivolve, Inc. engages in seeking technologies, ground-breaking innovations, and exclusive partnerships to help combat COVID-19 and generate risk-adjusted returns for investors. The company is headquartered in Toronto, Ontario. The company went IPO on 2009-11-16. The firm is engaged in providing telehealth platform, a clinical diagnostic network, and a data driven artificial intelligence (AI) framework to improve patient care. The company offers a network of retail collection sites, which provides clinical services in diagnostic testing, vaccinations, and other point-of-care services. The company is also engaged in developing technologies to identify, treat, and prevent medical issues. The company provides solution in COVID-19 testing, immunity scoring, and vaccinations. Its COVID-19 Testing includes rapid antibody blood test, reverse transcription (RT)- polymerase chain reaction (PCR) test and antigen test. The firm uses channel partner Aditxt Therapeutics, Inc. (Aditxt) to offer COVID-19 immunity status monitoring through its mobile testing centers.

MEDVF Intrinsic Value
0.004 USD
Overvaluation 26%
Intrinsic Value
Price

See Also

What is Medivolve Inc's Revenue?
Revenue
686.5k CAD

Based on the financial report for Dec 31, 2023, Medivolve Inc's Revenue amounts to 686.5k CAD.

What is Medivolve Inc's Revenue growth rate?
Revenue CAGR 3Y
-60%

Over the last year, the Revenue growth was -51%. The average annual Revenue growth rates for Medivolve Inc have been -60% over the past three years .

Back to Top